Related Experiment Video
Updated: Jan 27, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID.
Samuel B K Keat1, Priyanka Khatri2, Youssif M Ali2,3
1Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.
Long COVID is linked to complement dysregulation, particularly the lectin pathway. Elevated mannan-binding lectin-associated serine protease-2 (MASP-2)/C1Inh complexes indicate lectin pathway activation in long COVID patients.
Area of Science:
- Immunology
- Complement System Biology
- Infectious Disease Pathophysiology
Background:
- Long COVID, a condition affecting SARS-CoV-2 survivors, presents diverse symptoms impacting quality of life.
- Chronic inflammation and complement system dysregulation are implicated in long COVID's etiology.
- Previous studies noted elevated complement pathway activation markers in long COVID patients.
Purpose of the Study:
- To investigate the role of the lectin complement pathway in long COVID.
- To identify potential biomarkers for long COVID using complement analytes.
- To analyze mannan-binding lectin-associated serine protease-2 (MASP-2)/C1Inh complexes in long COVID patients.
Main Methods:
- Analysis of MASP-2/C1Inh complexes in a cohort of 159 long COVID patients and 76 healthy convalescents.
- Integration of data with other predictive complement analytes.
- Application of generalized linear modeling and receiver operating characteristic (ROC) analysis.
Main Results:
- MASP-2/C1Inh complexes were significantly elevated in long COVID patients (p=0.0003).
- An optimal biomarker set (iC3b, TCC, MASP-2/C1Inh, properdin) achieved an ROC predictive power of 0.796.
- Classical complement pathway markers showed poor predictive value for long COVID.
Conclusions:
- Lectin complement pathway activation is a significant feature of long COVID.
- The lectin pathway, upstream of alternative and terminal pathways, is a potential therapeutic target.
- A combination of complement markers can effectively predict long COVID status.
More Related Videos
Related Concept Videos
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Other Glycolytic Pathways

